Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.35
08.02.21
€9.00
08.02.22
-1.36%
22.02.21

Could be very worthwhile Investment >20% year
buy
Overstock.com

Start price
Target price
Perf. (%)
€79.50
08.02.21
-
08.02.22
-13.48%
27.07.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
buy
eHealth Inc.

Start price
Target price
Perf. (%)
€48.35
08.02.21
-
08.02.22
16.56%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Synaptics Inc.

Start price
Target price
Perf. (%)
€98.50
08.02.21
-
08.02.22
17.77%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€14.13
08.02.21
-
-36.12%
21.02.21

Could be very worthwhile Investment >20% year
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€5.90
08.02.21
-
08.02.22
-20.34%
10.02.21

Could be very worthwhile Investment >20% year
Some uniques
Known brand
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€22.22
08.02.21
-
08.02.22
-2.61%
22.02.21

Could be worthwhile Investment >10% per year
Small cyclical dependencies
International Flavors & Fragrances Inc.

Start price
Target price
Perf. (%)
€91.86
08.02.21
-
08.02.22
-
08.02.21

Risky Investment
buy
Zynga Inc.

Start price
Target price
Perf. (%)
€9.00
07.02.21
€10.00
07.02.22
-30.00%
01.11.21

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Inpixon

Start price
Target price
Perf. (%)
€111.75
07.02.21
€22.50
07.02.22
-74.54%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Stericycle Inc.

Start price
Target price
Perf. (%)
€57.18
07.02.21
-
07.02.22
5.35%
21.06.21

Probably not worthwhile Investment
Low dividend yield expected
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.88
07.02.21
€5.00
07.02.22
-66.49%
08.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
buy
Inpixon

Start price
Target price
Perf. (%)
€111.75
07.02.21
€225.00
07.02.22
-74.54%
08.02.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Marin Software

Start price
Target price
Perf. (%)
€2.30
07.02.21
€10.00
07.02.22
20.00%
08.02.22

Could be very worthwhile Investment >20% year
Very small cyclical dependencies
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€143.50
07.02.21
-
07.02.22
0.42%
20.02.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Gamestop Corp.

Start price
Target price
Perf. (%)
€14.13
07.02.21
-
07.02.22
-27.69%
16.02.21

Risky Investment
overvalued
Outdated or very high risk business model
High risks in the balance sheet
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€5.90
07.02.21
-
07.02.22
-22.03%
16.02.21

overvalued
Outdated or very high risk business model
Risky Investment
Significant cyclical dependencies
buy
Greenhill & Co.inc.

Start price
Target price
Perf. (%)
€13.00
06.02.21
€15.00
06.02.22
20.00%
05.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
buy
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€137.50
06.02.21
€150.00
06.02.22
-67.82%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
MaxCyte Inc

Start price
Target price
Perf. (%)
€10.00
06.02.21
€10.00
06.02.22
33.00%
12.08.21

Capable Management
Future proof or reliable business model
Higher risks for its business
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€416.00
06.02.21
-
06.02.22
7.91%
25.05.21

EBIT growth >5% per year expected
Very low/no dividend yield expected
Fifth Third Bancorp

Start price
Target price
Perf. (%)
€26.60
06.02.21
-
06.02.22
41.35%
13.12.21

Very high dividend yield expected
Business model of the past or high risk
Higher risks for its business